Jpmorgan Chase & CO Xenon Pharmaceuticals Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 976,783 shares of XENE stock, worth $37.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

976,783

Previous 71,654 1263.19%

Holding current value

$37.4 Million

Previous $2.79 Million 1276.15%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$36.12 - $43.96 $32.7 Million - $39.8 Million	905,129 Added 1263.19%	976,783 $38.4 Million
Q2 2024 Aug 12, 2024	BUY	$36.25 - $43.75 $1.27 Million - $1.53 Million	35,033 Added 95.66%	71,654 $2.79 Million
Q1 2024 May 10, 2024	SELL	$42.66 - $50.04 $689,684 - $808,996	-16,167 Reduced 30.63%	36,621 $1.58 Million
Q4 2023 Feb 12, 2024	BUY	$28.7 - $46.46 $71,491 - $115,731	2,491 Added 4.95%	52,788 $2.43 Million
Q3 2023 Nov 14, 2023	SELL	$34.16 - $39.73 $987,907 - $1.15 Million	-28,920 Reduced 36.51%	50,297 $1.72 Million
Q2 2023 Aug 11, 2023	BUY	$34.84 - $43.54 $1.62 Million - $2.02 Million	46,430 Added 141.61%	79,217 $3.05 Million
Q1 2023 May 11, 2023	BUY	$33.46 - $40.35 $1.03 Million - $1.24 Million	30,700 Added 1471.01%	32,787 $1.17 Million
Q4 2022 Feb 13, 2023	SELL	$33.06 - $39.43 $72,203 - $86,115	-2,184 Reduced 51.14%	2,087 $82,000
Q3 2022 Nov 14, 2022	BUY	$30.79 - $39.82 $56,191 - $72,671	1,825 Added 74.61%	4,271 $155,000
Q2 2022 Aug 11, 2022	SELL	$25.44 - $35.16 $99,852 - $138,003	-3,925 Reduced 61.61%	2,446 $74,000
Q1 2022 May 11, 2022	BUY	$25.09 - $33.13 $40,043 - $52,875	1,596 Added 33.42%	6,371 $194,000
Q4 2021 Feb 10, 2022	BUY	$15.6 - $35.4 $27,471 - $62,339	1,761 Added 58.43%	4,775 $149,000
Q3 2021 Nov 12, 2021	BUY	$14.86 - $19.45 $44,788 - $58,622	3,014 New	3,014 $46,000

Others Institutions Holding XENE

# of Institutions

212

Shares Held

70.2M

Call Options Held

88.3K

Put Options Held

28.8K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.39B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Xenon Pharmaceuticals Inc. Transaction History